posted on 2023-07-25, 02:11authored byD Kaiserman, P Zhao, CL Rowe, A Leong, N Barlow, LT Joeckel, C Hitchen, Sarah StewartSarah Stewart, MD Hollenberg, N Bunnett, A Suhrbier, PI Bird
Granzyme K (GzmK) is a tryptic member of the granzyme family of chymotrypsin-like serine proteases produced by cells of the immune system. Previous studies have indicated that GzmK activates protease-activated receptor 1 (PAR1) enhancing activation of monocytes and wound healing in endothelial cells. Here, we show using peptides and full length proteins that GzmK and, to a lesser extent the related protease GzmA, are capable of activating PAR1 and PAR2. These cleavage events occur at the canonical arginine P1 residue and involve exosite interactions between protease and receptor. Despite cleaving PAR2 at the same point as trypsin, GzmK does not induce a classical Ca2+ flux but instead activates a distinct signalling cascade, involving recruitment of β-arrestin and phosphorylation of ERK. In epithelial A549 cells, PAR2 activation by GzmK results in the release of inflammatory cytokines IL-6 and IL-8. These data suggest that during an immune response GzmK acts as a pro-inflammatory regulator, rather than as a cytotoxin.
Funding
This work was funded by a National Health and Medical Research Council Australia Project Grant 1141421 (PIB & AS), a National Health and Medical Research Council Australia Program Grant 490900 (PIB), National Institutes of Health grants NS102722, DE026806, DK118971 and DE029951 (NB) and Department of Defense grant W81XWH1810431 (NB).